ArticleCureus2025
The Effect of Autologous Blood Transfusion in Open Heart Procedures on the Requirement of Allogeneic Blood Products.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives The aim of the study was to evaluate the effect of autologous blood transfusion on the requirement of allogeneic blood products and the change in hemoglobin levels in open heart procedures. Patients and methods The study included 59 patients who underwent open heart procedures from July 2020 to August 2022. Group 1 (35 patients) received an autologous blood transfusion, and group 2 (24 patients) did not receive an autologous transfusion. The requirement of allogeneic blood components and other demographic and clinical parameters were compared between the two groups. Results In the autologous group, 22 (62.9%) patients underwent valve replacement, 9 (25.7%) patients underwent on-pump coronary artery bypass grafting, and 4 (11.4%) patients other procedures (atrial septal defect closure, pulmonary stenosis), whereas in the non-autologous group, 19 (79.7%) patients underwent valve replacement, 3 (12.5%) patients underwent on-pump coronary artery bypass, and 2 (8.33%) patients underwent other on pump procedures. The comparison of the change in hemoglobin levels after surgery between the two groups was statistically significant, with greater change seen in the autologous group. The requirement for blood products was more in group 2, but the difference was not statistically significant. Conclusion Use of autologous blood during cardiac surgery on pump did not reveal any significant advantage. On the contrary, change in hemoglobin from preoperative to postoperative levels was greater in the autologous group as compared to the non-autologous group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.